An appropriations package, signed earlier this month by President Biden, will increase funding by $100 million for research into Alzheimer’s disease and other types of dementia at the National Institutes of Health for the fiscal year 2024. The new law, approved with bipartisan support, will allocate $34 million to fund and continue to implement a law known as the “Building Our Largest Dementia Infrastructure for Alzheimer’s Reauthorization Act of 2024” or the “BOLD Infrastructure for Alzheimer’s Reauthorization Act of 2024.” This funding will serve to “drive innovation and accelerate improvements in care, treatment and prevention for Alzheimer’s and all other dementia,” Robert Egge, the Alzheimer’s Association’s chief public policy officer, said in a statement.